Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 1/20 | 0.52 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.52 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.39 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28333341 | 0.98 | LPAR3 (0.55) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL19307697 | 0.98 | LPAR3 (0.55) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL26828205 | 0.98 | LPAR3 (0.55) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL23630511 | 0.98 | LPAR3 (0.55) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL7902422 | 0.98 | LPAR3 (0.55) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL23630464 | 0.98 | LPAR3 (0.55) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL4950107 | 0.98 | LPAR3 (0.55) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL4821027 | 0.92 | — | — | |
| Butane SCHEMBL15477382 | 0.84 | LPAR3 (0.52) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL585465 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115334884-B | Clomazone composition for improving nitrogen nutrient use efficiency and plant growth | 沃戴申生命科学美国有限责任公司 | 2025-01-07 | — | — | CN | disclosed |
| US-20240254287-A1 | Thiol-ene-based polymerizable composition | KARL LEIBINGER ASSET MANAGEMENT GMBH & CO. KG (DE) | 2024-08-01 | — | — | US | disclosed |
| US-20230035913-A1 | NITRAPYRIN COMPOSITIONS FOR ENHANCING NITROGEN NUTRIENT USE EFFICIENCY AND IMPROVING PLANT GROWTH | VERDESIAN LIFE SCIENCES U.S., LLC | 2023-02-02 | — | — | US | disclosed |
| US-20220389245-A1 | METAL OXIDE NANOPARTICLES | BASF SE (DE) | 2022-12-08 | — | — | US | disclosed |
| CN-115334884-A | Chlorodiidine compositions for increasing nitrogen nutrient use efficiency and improving plant growth | 沃戴申生命科学美国有限责任公司 | 2022-11-11 | — | — | CN | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| CN-110945084-B | Phosphonate surface functionalized titanium dioxide nanoparticles | 巴斯夫欧洲公司 | 2022-05-10 | — | — | CN | disclosed |
| US-11274219-B2 | Surface functionalized titanium dioxide nanoparticles | BASF SE (DE) | 2022-03-15 | — | — | US | disclosed |
| WO-2021141855-A1 | NITRAPYRIN COMPOSITIONS FOR ENHANCING NITROGEN NUTRIENT USE EFFICIENCY AND IMPROVING PLANT GROWH | VERDESIAN LIFE SCIENCES U.S., LLC (US) | 2021-07-15 | — | — | WO | disclosed |
| CN-110669458-B | Resin composition | 苏州星烁纳米科技有限公司 | 2021-06-29 | — | — | CN | disclosed |
| US-20200165471-A1 | SURFACE FUNCTIONALIZED TITANIUM DIOXIDE NANOPARTICLES | BASF SE (DE) | 2020-05-28 | — | — | US | disclosed |
| CN-110945084-A | Phosphonate surface functionalized titanium dioxide nanoparticles | 巴斯夫欧洲公司 | 2020-03-31 | — | — | CN | disclosed |
| CN-110669458-A | Resin composition | 苏州星烁纳米科技有限公司 | 2020-01-10 | — | — | CN | disclosed |
| CN-107760232-B | resin composition, light conversion element, and light source module | 苏州星烁纳米科技有限公司 | 2019-12-17 | — | — | CN | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |
| CN-107760232-A | Resin composition, light conversion element, and light source module | 苏州星烁纳米科技有限公司 | 2018-03-06 | — | — | CN | disclosed |
| WO-2008120854-A1 | FLAMEPROOF COPOLYMER AND FLAME RETARDANT THERMOPLASTIC RESIN COMPOSITION USING THEREOF | CHEIL INDUSTRIES INC. (KR) | 2008-10-09 | — | — | WO | disclosed |
| US-20080242795-A1 | Flameproof Copolymer and Flame Retardant Thermoplastic Resin Composition Including the Same | CHEIL INDUSTRIES INC. (KR) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230035913-A1 | NITRAPYRIN COMPOSITIONS FOR ENHANCING NITROGEN NUTRIENT USE EFFICIENCY AND IMPROVING PLANT GROWTH | NANS, PNPO, PNP | TYMS 440/4885LPAR3 4767/4885LPAR2 4776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.